NASDAQ: APYX
Apyx Medical Corp Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their APYX stock forecasts and price targets.

Forecast return on equity

Is APYX forecast to generate an efficient return?

Company
-82.45%
Industry
20.08%
Market
76.96%
APYX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is APYX forecast to generate an efficient return on assets?

Company
-18.07%
Industry
10.81%
APYX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

APYX earnings per share forecast

What is APYX's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.34
Avg 2 year Forecast
-$0.31

APYX revenue forecast

What is APYX's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$48.5M+0.85%
Avg 2 year Forecast
$51.0M+6.09%
APYX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

APYX revenue growth forecast

How is APYX forecast to perform vs Medical Devices companies and vs the US market?

Company
0.85%
Industry
7.78%
Market
59.56%
APYX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
APYX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

APYX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
APYX$0.98N/AN/A
OM$9.98$45.00+350.90%Hold
PTHL$2.72N/AN/A
TELA$0.89$5.33+499.21%Buy
MODD$0.85N/AN/A

Apyx Medical Stock Forecast FAQ

What is APYX's earnings growth forecast for 2025-2026?

(NASDAQ: APYX) Apyx Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 52.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.

Apyx Medical's earnings in 2025 is -$23,463,000.On average, 1 Wall Street analyst forecast APYX's earnings for 2025 to be -$12,849,921, with the lowest APYX earnings forecast at -$12,849,921, and the highest APYX earnings forecast at -$12,849,921.

In 2026, APYX is forecast to generate -$11,716,105 in earnings, with the lowest earnings forecast at -$11,716,105 and the highest earnings forecast at -$11,716,105.

If you're new to stock investing, here's how to buy Apyx Medical stock.

What is APYX's revenue growth forecast for 2025-2026?

(NASDAQ: APYX) Apyx Medical's forecast annual revenue growth rate of 0.85% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.56%.

Apyx Medical's revenue in 2025 is $48,102,000.On average, 1 Wall Street analysts forecast APYX's revenue for 2025 to be $1,833,381,410, with the lowest APYX revenue forecast at $1,833,381,410, and the highest APYX revenue forecast at $1,833,381,410.

In 2026, APYX is forecast to generate $1,928,622,003 in revenue, with the lowest revenue forecast at $1,928,622,003 and the highest revenue forecast at $1,928,622,003.

What is APYX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: APYX) forecast ROA is -18.07%, which is lower than the forecast US Medical Devices industry average of 10.81%.

What is APYX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: APYX) Apyx Medical's current Earnings Per Share (EPS) is -$0.66. On average, analysts forecast that APYX's EPS will be -$0.34 for 2025, with the lowest EPS forecast at -$0.34, and the highest EPS forecast at -$0.34. In 2026, APYX's EPS is forecast to hit -$0.31 (min: -$0.31, max: -$0.31).

What is APYX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: APYX) forecast ROE is -82.45%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.